White House pulls drug rebate rule
Biosimilars show market failure
JNJ earnings preview
Are new peanut allergy treatments worth the cost
*scroll through previous pages at the bottom to get older news*
Want to stay updated on CP happenings? New features, new boards, CP wire articles, and more? Click here to subscribe